2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
6276
Carcinoma, Renal Cell
1915
Urinary Bladder Neoplasms
1672
Kidney Neoplasms
931
Breast Neoplasms
794
Neoplasms
791
Carcinoma, Transitional Cell
597
Carcinoma, Non-Small-Cell Lung
525
Neoplasm Metastasis
511
Melanoma
486
Ovarian Neoplasms
470
Colorectal Neoplasms
456
Lung Neoplasms
436
Pancreatic Neoplasms
326
Testicular Neoplasms
290
Stomach Neoplasms
274
Sarcoma
267
Uterine Cervical Neoplasms
265
Non-Muscle Invasive Bladder Neoplasms
264
Head and Neck Neoplasms
242
Colonic Neoplasms
217
Esophageal Neoplasms
203
Squamous Cell Carcinoma of Head and Neck
202
Carcinoma, Hepatocellular
200
Wilms Tumor
196
Endometrial Neoplasms
191
Recurrence
162
Urologic Neoplasms
149
Neuroblastoma
148
Small Cell Lung Carcinoma
146
Interventions
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
×
Genitourinary
×
Clear all
NCT01780220
2022-05-19
CARLHA
UNICANCER
Phase 1/2
Completed
47 enrolled